Introducing
GambitBio
Empowering you and your family to outsmart cancer with an at-home low cost, saliva based lateral flow test to screen for the most common cancers. Early detection is the key to curing cancer.
Why GambitBio?
Accuracy
Bringing state-of-the-art science from the lab to you in the form of novel and accurate biomarkers used in the test kit.
Efficiency
A direct-to-consumer product you can purchase from the pharmacy or online – no need for going into the hospital or clinic! Do the test and read the results within 30 minutes.
Peace-of-mind
Test yourself for the conditions you’re at risk for at home in between official hospital or clinic screening (just as often as you’d visit the dentist).
At-Home
Use the test from the comfort and privacy of your own home (or wherever you want!)
Follow Up
Our smart phone companion app allows you to track the past tests you’ve taken and to get reminders for future tests. If appropriate, it will also link you to your GP for a follow-up test in the clinic.
Empowerment
A strategic and convenient way to stay on top of your health – to beat cancer by being one step ahead.
Together, We Can Outsmart Cancer
Equipping individuals and families to stay one step ahead of cancer, our at-home, affordable saliva-based lateral flow test is designed for early screening of prevalent cancers.
With early detection as our cornerstone, we aim to shift the perception of cancer from fear to manageability, fostering a proactive approach to health and well-being.
No Blood, No Needles
Lateral flow tests provide rapid results by detecting the presence of a target substance in a sample without the need for specialized equipment, while PCR tests offer highly sensitive and specific detection of genetic material but require laboratory processing and more time to deliver results.
Hassle-Free Testing
Our test offers a hassle-free way to check your health, with results in just minutes from a simple saliva sample—no appointments or labs required. It's health monitoring made easy, fitting seamlessly into your daily routine.
What is the GambitBio test?
At Gambit Bio, we have pioneered a lateral flow test (LFT) that utilizes cutting-edge proprietary biomarkers, targeting unique post-translational modifications in proteins. This approach, largely untapped due to past technical constraints, allows our LFTs to capture a richer set of data, significantly enhancing their accuracy in detecting cancer.
Our innovation embodies our commitment to transforming cancer diagnostics, making early detection more accessible and reliable.
Who We Are
At Gambit Bio, we are a team of dedicated innovators and researchers committed to transforming the landscape of cancer diagnostics. Our diverse group, consisting of experts in molecular biology, oncology, and biotechnology, brings together a wealth of knowledge and experience to pioneer accessible, early-stage cancer detection solutions.
United by a common vision, we each contribute unique insights and expertise to empower individuals globally in their fight against cancer.
CEO & Co-Founder
CTO & Co-Founder
CMO & Co-Founder
CSO & Co-Founder
Advisor
Board Chair
GambitBio in the news
Progress to date
Have Questions?
-
GambitBio is still in its product development stage and we aren’t ready for distribution yet. Please subscribe to our communication channels and watch this space!
-
No, this test is designed to be distributed over-the-counter. All customers should be able to access the test without any prescription from their primary care provider (PCP/GP).
-
We would recommend you to reach out to your primary care provider (PCP/GP) for additional testing. This test serves as a screening or risk factor tool for the probability of cancer presence and is not an official diagnostic kit.
For Investors
-
To reach us, you can directly message us on our Linkedin or our official instagram page (@gambitbio) or email us at gambitbio@gmail.com
-
We are currently raising a SAFE round - interested angels and VCs, please get in touch.
-
Want to help us revolutionise the future of at-home cancer testing, as an advisor, collaborator or intern? Reach out to us at gambitbio@gmail.com or direct message us through our instagram (@gambitbio) and LinkedIn.
Reach out to learn more
Join us on our mission to redefine cancer diagnostics. Whether you're seeking more information or interested in investment opportunities, your partnership can contribute to a future where early cancer detection is in everyone’s reach.
Contact us to explore how we can make a difference together.